Zhejiang Jiaoke: the amount of newly signed orders in the first quarter was 9.488 billion yuan, and the order stock was sufficient

Survival Rules for Turbulent Times: A Compilation of the 20 Most Unmissable Core Insights from the 2026 Tsinghua PBCSF Forum

A dialogue between Zhu Min, former Deputy Governor of the People's Bank of China and former Vice Managing Director of the International Monetary Fund; Michael Spence, 2001 Nobel Prize winner in Economics and Philip H. Knight Professor Emeritus of Management at Stanford Graduate School of Business; and Masaaki Shirakawa, former Governor of the Bank of Japan, at the 2026 Tsinghua PBCSF Global Finance Forum.

Unpacking China | Key Chinese Firms to Watch This Week （18/10/2026-24/10/2026）

Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.

Neolix Raises Nearly US$400 Million in Series E to Expand Autonomous Delivery Network

Neolix（新石器）announced on October 20 that it had completed a Series E financing round of nearly US$400 million, with proceeds earmarked for regional service hubs and autonomous-driving technology. The company says its global fleet now exceeds 30,000 Level 4 delivery vehicles, although overseas deployments remain at different stages of testing and commercial operation.

Axera’s ADAS Chip Enters Europe Through Leapmotor Electric Hatchback

Axera（爱芯元智）said on October 20 that its advanced driver-assistance chip had entered the European market in a new compact electric hatchback from Leapmotor（零跑汽车）. The deployment extends the Chinese chip designer’s overseas reach through an existing automotive customer rather than a separately announced supply agreement with a European automaker.

CTTQ, Ampsourcebio Ink Agreement on Cure for NASH, T2DM

There are more than 95 plus major players and more than 90 plus nonalcoholic steatohepatitis (NASH) pipeline therapies, but none of them has been approved for marketing. Who would survive the competition in the blue-ocean market for NASH?